Blog - Page 1404 of 5718

TuesdayMay 04, 2021 12:45 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Set for ‘Strong Foray’ into Insurtech, Predictive Services

FingerMotion (OTCQX: FNGR) operates primarily in China to deliver mobile tech-related services with an aim to acquire more than a billion customers for its mobile payment, mobile phone recharge platform and insurtech services through a step-by-step developmental strategy. “FingerMotion’s service offerings include telecommunication products and services and SMS and MMS services, the company’s core revenue sources, as well as the rich communication services and big-data insights launching this year,” reads a recent article discussing the company’s positioning. “The big data product has the potential to provide the foundation for the company’s ‘strong foray’ into insurtech offerings as well as predictive…

TuesdayMay 04, 2021 12:43 pm

FingerMotion Inc. (FNGR) Leveraging Raw Mobile Data to Offer Big Data Insights

FingerMotion has forged strong relationships with the three largest telecommunication companies in China The relationships have given FNGR access to subscriber data, allowing it to test its proprietary data analytics algorithms in real-time The algorithms, created by FingerMotion’s Big Data Insights Division, leverage raw mobile data to create a user persona A technological company, FingerMotion (OTCQX: FNGR) has evolved over the years. What began as a mobile gaming company, launched in 2016, morphed into a mobile payment and recharge service provider in 2018, offering these services to China Unicom’s (NYSE: CHU) customers. That same year, FNGR was awarded a contract…

TuesdayMay 04, 2021 12:33 pm

QualityStocksNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Holds Unique View Across EV Value Chain

Ideanomics (NASDAQ: IDEX) is a global company facilitating the adoption of commercial electric vehicles and supporting next-generation financial services and fintech products. The global company is driving next generation solutions to energy consumption and, through its Ideanomics Mobility division, has evolved into a synergistic ecosystem of subsidiaries and investments in the electric vehicle (“EV”) industry. A recent article regarding this quotes Ideanomics CEO Alf Poor, stating “We have a unique view across what we believe is the EV value chain because we have operations in China, South Asia, in Malaysia, in Europe and in North America, and we have interesting…

TuesdayMay 04, 2021 12:25 pm

QualityStocksNewsBreaks – First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) Releases Additional Assay Results from Augustus Lithium Property

First Energy Metals (CSE: FE) (OTCQB: FEMFF), a publicly traded Canadian mineral exploration company, has announced additional assay results from the channel sampling program conducted at its Augustus Lithium Property in Quebec. The samples taken from the Beluga Pegmatite of the Canadian Lithium Prospect cut a 31-meter-wide section with an average of 0.37% lithium oxide (Li2O), which includes four meters of spodumene pegmatite at 1.20$ Li2O. The company has been doing continuous ground exploration work since February with the objective of locating and confirming historical lithium pegmatite occurrences on two of its locations: Augustus and Canadian Lithium Prospects. The work, which includes field exploration…

TuesdayMay 04, 2021 12:18 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Commences Site Recruitment for Acclaim-2 Clinical Trial

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced it has commenced clinical trial site recruitment for its upcoming Acclaim-2 clinical trial for the treatment of non-small cell lung cancer (“NSCLC”). An open-label, multicenter Phase 1/2 clinical trial, Acclaim-2 combines Genprex’s lead drug candidate, REQORSA(TM) immunogene therapy, with Merck & Co Inc.’s Keytruda in patients with late-stage NSCLC who are low expressors (1% to 49%) of the protein programmed death-ligand 1 ("PD-L1"). “Our clinical team remains focused on engaging with leading clinical investigators and esteemed research institutions in…

TuesdayMay 04, 2021 11:55 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Launches New Line, Implements Changes Under New Leadership

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) has launched a new line of premium organically grown cannabis. The new line comes as a result of the company’s new leadership organization, which started in fall 2020 and focused on restoring TGOD’s position as a premium organic cannabis brand. In addition to the new product line the company has implemented new cultivation and processing methods and updated label and packaging to improve transparency and reduce environmental impact. Finally, all TGOD premium organic whole flower cannabis products feature THC levels of at least 20%. "Our new leadership team started in the fall…

TuesdayMay 04, 2021 11:44 am

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) Featured in Stock2Me Podcast

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a leading provider of web-based augmented reality for e-commerce, advertising and virtual events, was featured in the latest episode of The Stock2Me Podcast, an InvestorBrandNetwork (“IBN”) solution to provide specialized content distribution via widespread syndication channels. Nextech President Paul Duffy joined the latest episode to discuss the company’s technology and its distinct capability to augment views and superimpose holograms to physical locations. “What makes us different is that we put augmented reality into everything that we do. AR is the ability to take photorealistic objects – it could be people, products…

TuesdayMay 04, 2021 11:41 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leading Charge in Developing Psychedelic Medicines for Treating Rare Eating Disorders

Pharmaceutical developer Tryp Therapeutics is targeting orphan disorders with novel medicinal solutions The company’s initial candidates seeking regulatory approval are a psilocybin compound for treating fibromyalgia, eating disorders and chronic pain conditions, as well as a tumor-inhibiting drug for treating soft tissue sarcomas Tryp has partnered with the University of Florida to conduct a Phase 2a clinical trial for eating disorders using Tryp's psilocybin product Following a year in which a global pandemic led to heightened concerns about individuals’ mental well-being while navigating the health emergency’s effects on society (https://ibn.fm/YGqDb), proponents of psychedelic medicine development programs gained stronger allies in…

TuesdayMay 04, 2021 11:04 am

RYAH Group About to Start Trading on Canadian Securities Exchange

RYAH Group to start trading on Canadian Securities Exchange following a transaction involving a triangular merger RYAH Group is digital health care analytics and technology company developing innovative solutions for the plant-based medical industry RYAH is poised for growth as the world transitions to remote health at an accelerated pace due to the pandemic RYAH Group (formerly known as Prime Blockchain Inc.) will start trading on the Canadian Securities Exchange under the ticker symbol "RYAH" today (https://ibn.fm/Z6gZj). The New York-based digital health care analytics and technology company is focused on the development and commercialization of innovative technology, including software and…

TuesdayMay 04, 2021 10:48 am

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Announces Launch of Biotechnology Innovations Hub – TruLife Biotech LLC.

Green Hygienics Holdings (OTCQB: GRYN), a company focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, today announced its intention to move forward with the establishment of TruLife Biotech LLC. According to the update, TruLife Biotech will focus on the development and advancement of innovative cannabinoid-based nutraceuticals, skincare products and wellness brands addressing endocannabinoid system (“ECS”) deficiencies in humans. “The interaction of hemp-derived cannabinoids with ECS has been rigorously studied for the last 20 years… In order to recommend a particular cannabinoid-based product to wellness-oriented end users and practitioners, product developers need to…

Site Search

Company Search